Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Gastric Cancer

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 68 articles: HTML format Text format

Single Articles

June 2018
1. HU C, Zhou Y, Liu C, Kang Y, et al
   A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
   Int J Oncol. 2018 Jun 6. doi: 10.3892/ijo.2018.4433.
   PubMed     Text format     Abstract available
   
   
   May 2018
2. OKUGAWA Y, Toiyama Y, Ichikawa T, Kawamura M, et al
   Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.
   Int J Oncol. 2018 May 16. doi: 10.3892/ijo.2018.4406.
   PubMed     Text format     Abstract available
   
   
   April 2018
3. WANG J, Liang WJ, Min GT, Wang HP, et al
   LTBP2 promotes the migration and invasion of gastric cancer cells and predicts poor outcome of patients with gastric cancer.
   Int J Oncol. 2018 Apr 4. doi: 10.3892/ijo.2018.4356.
   PubMed     Text format     Abstract available
   
   
   March 2018
4. YU S, Li L, Wu Q, Dou N, et al
   PPP2R2D, a regulatory subunit of protein phosphatase 2A, promotes gastric cancer growth and metastasis via mechanistic target of rapamycin activation.
   Int J Oncol. 2018 Mar 20. doi: 10.3892/ijo.2018.4329.
   PubMed     Text format     Abstract available
   
   
   February 2018
5. ZHOU D, Zhou Y, Li C, Yang L, et al
   Silencing of B7-H4 suppresses the tumorigenicity of the MGC-803 human gastric cancer cell line and promotes cell apoptosis via the mitochondrial signaling pathway.
   Int J Oncol. 2018 Feb 13. doi: 10.3892/ijo.2018.4274.
   PubMed     Text format     Abstract available
   
   
   
6. LU M, Huang Y, Sun W, Li P, et al
   miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
   Int J Oncol. 2018;52:589-598.
   PubMed     Text format     Abstract available
   
   
   
7. LI L, Yang D, Cui D, Li Y, et al
   Quantitative proteomics analysis of the role of tetraspanin-8 in the drug resistance of gastric cancer.
   Int J Oncol. 2018;52:473-484.
   PubMed     Text format     Abstract available
   
   
   January 2018
8. LIAN G, Li L, Shi Y, Jing C, et al
   BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
   Int J Oncol. 2018 Jan 25. doi: 10.3892/ijo.2018.4255.
   PubMed     Text format     Abstract available
   
   
   
9. FEI HJ, Chen SC, Zhang JY, Li SY, et al
   Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis.
   Int J Oncol. 2018 Jan 11. doi: 10.3892/ijo.2018.4243.
   PubMed     Text format     Abstract available
   
   
   
10. ARAI H, Wada R, Ishino K, Kudo M, et al
    Expression of DNA damage response proteins in gastric cancer: Comprehensive protein profiling and histological analysis.
    Int J Oncol. 2018 Jan 5. doi: 10.3892/ijo.2018.4238.
    PubMed     Text format     Abstract available
    
    
    December 2017
11. YAN H, Xiao F, Zou J, Qiu C, et al
    NR4A1-induced increase in the sensitivity of a human gastric cancer line to TNFalpha-mediated apoptosis is associated with the inhibition of JNK/Parkin-dependent mitophagy.
    Int J Oncol. 2017 Dec 4. doi: 10.3892/ijo.2017.4216.
    PubMed     Text format     Abstract available
    
    
    October 2017
12. WANG YM, Gu ML, Meng FS, Jiao WR, et al
    Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines.
    Int J Oncol. 2017 Oct 23. doi: 10.3892/ijo.2017.4176.
    PubMed     Text format     Abstract available
    
    
    
13. LIU Y, Zhang C, Zhao L, Du N, et al
    APPL1 promotes the migration of gastric cancer cells by regulating Akt2 phosphorylation.
    Int J Oncol. 2017;51:1343-1351.
    PubMed     Text format     Abstract available
    
    
    
14. ZHOU J, Wu X, Li G, Gao X, et al
    Prediction of radiosensitive patients with gastric cancer by developing gene signature.
    Int J Oncol. 2017;51:1067-1076.
    PubMed     Text format     Abstract available
    
    
    September 2017
15. WANG G, Huang YX, Zhang R, Hou LD, et al
    Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC7901 cells partly via miR200amediated downregulation of beta-catenin pathway.
    Int J Oncol. 2017 Sep 27. doi: 10.3892/ijo.2017.4139.
    PubMed     Text format     Abstract available
    
    
    
16. WEI F, Jiang X, Gao HY, Gao SH, et al
    Liquiritin induces apoptosis and autophagy in cisplatin (DDP)-resistant gastric cancer cells in vitro and xenograft nude mice in vivo.
    Int J Oncol. 2017 Sep 22. doi: 10.3892/ijo.2017.4134.
    PubMed     Text format     Abstract available
    
    
    August 2017
17. PAN Z, Tian Y, Zhang B, Zhang X, et al
    YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression.
    Int J Oncol. 2017 Aug 23. doi: 10.3892/ijo.2017.4101.
    PubMed     Text format     Abstract available
    
    
    July 2017
18. LEE H, Saini N, Parris AB, Zhao M, et al
    Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling.
    Int J Oncol. 2017 Jul 13. doi: 10.3892/ijo.2017.4073.
    PubMed     Text format     Abstract available
    
    
    
19. XU M, Qin S, Cao F, Ding S, et al
    MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
    Int J Oncol. 2017 Jul 12. doi: 10.3892/ijo.2017.4072.
    PubMed     Text format     Abstract available
    
    
    May 2017
20. KIM B, Kim YS, Ahn HM, Lee HJ, et al
    Peroxiredoxin 5 overexpression enhances tumorigenicity and correlates with poor prognosis in gastric cancer.
    Int J Oncol. 2017 May 19. doi: 10.3892/ijo.2017.4013.
    PubMed     Text format     Abstract available
    
    
    
21. DU Y, Jiang B, Song S, Pei G, et al
    Metadherin regulates actin cytoskeletal remodeling and enhances human gastric cancer metastasis via epithelial-mesenchymal transition.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4002.
    PubMed     Text format     Abstract available
    
    
    
22. XIAO S, Zhou L
    Gastric cancer: Metabolic and metabolomics perspectives (Review).
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.4000.
    PubMed     Text format     Abstract available
    
    
    
23. GE L, Li DS, Chen F, Feng JD, et al
    TAZ overexpression is associated with epithelial-mesenchymal transition in cisplatin-resistant gastric cancer cells.
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.3998.
    PubMed     Text format     Abstract available
    
    
    
24. ZHUANG K, Zhang L, Zhang X, Tang H, et al
    Gastrin induces multidrug resistance via the degradation of p27Kip1 in the gastric carcinoma cell line SGC7901.
    Int J Oncol. 2017 May 4. doi: 10.3892/ijo.2017.3983.
    PubMed     Text format     Abstract available
    
    
    
25. ZENG XQ, Wang J, Chen SY
    Methylation modification in gastric cancer and approaches to targeted epigenetic therapy (Review).
    Int J Oncol. 2017 May 3. doi: 10.3892/ijo.2017.3981.
    PubMed     Text format     Abstract available
    
    
    
26. FUJIWARA Y, Okada K, Omori T, Sugimura K, et al
    Multiple therapeutic peptide vaccines for patients with advanced gastric cancer.
    Int J Oncol. 2017;50:1655-1662.
    PubMed     Text format     Abstract available
    
    
    April 2017
27. PAN Y, Shu X, Sun L, Yu L, et al
    miR196a5p modulates gastric cancer stem cell characteristics by targeting Smad4.
    Int J Oncol. 2017 Apr 19. doi: 10.3892/ijo.2017.3965.
    PubMed     Text format     Abstract available
    
    
    
28. WANG R, Song Y, Liu X, Wang Q, et al
    UBE2C induces EMT through Wnt/betacatenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.
    Int J Oncol. 2017;50:1116-1126.
    PubMed     Text format     Abstract available
    
    
    March 2017
29. HUANG T, Wang L, Liu D, Li P, et al
    FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1.
    Int J Oncol. 2017 Mar 22. doi: 10.3892/ijo.2017.3927.
    PubMed     Text format     Abstract available
    
    
    
30. WANG C, Yang C, Ji J, Jiang J, et al
    Deubiquitinating enzyme USP20 is a positive regulator of Claspin and suppresses the malignant characteristics of gastric cancer cells.
    Int J Oncol. 2017 Mar 8. doi: 10.3892/ijo.2017.3904.
    PubMed     Text format     Abstract available
    
    
    
31. NASSER MI, Masood M, Wei W, Li X, et al
    Cordycepin induces apoptosis in SGC7901 cells through mitochondrial extrinsic phosphorylation of PI3K/Akt by generating ROS.
    Int J Oncol. 2017;50:911-919.
    PubMed     Text format     Abstract available
    
    
    February 2017
32. SHEN L, Luo Z, Wu J, Qiu L, et al
    Enhanced expression of alpha2,3-linked sialic acids promotes gastric cancer cell metastasis and correlates with poor prognosis.
    Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3882.
    PubMed     Text format     Abstract available
    
    
    
33. FUJIMOTO D, Goi T, Hirono Y
    Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma.
    Int J Oncol. 2017;50:448-456.
    PubMed     Text format     Abstract available
    
    
    December 2016
34. LEE JH, Kim SS, Lee HS, Hong S, et al
    Upregulation of SMAD4 by MZF1 inhibits migration of human gastric cancer cells.
    Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3793.
    PubMed     Text format     Abstract available
    
    
    November 2016
35. LI R, Yang HQ, Xi HL, Feng S, et al
    Inhibition of CDH17 gene expression via RNA interference reduces proliferation and apoptosis of human MKN28 gastric cancer cells.
    Int J Oncol. 2016 Nov 28. doi: 10.3892/ijo.2016.3783.
    PubMed     Text format     Abstract available
    
    
    October 2016
36. XU M, Zhou H, Zhang C, He J, et al
    ADAM17 promotes epithelial-mesenchymal transition via TGF-beta/Smad pathway in gastric carcinoma cells.
    Int J Oncol. 2016 Oct 21. doi: 10.3892/ijo.2016.3744.
    PubMed     Text format     Abstract available
    
    
    September 2016
37. HUANG T, Wang-Johanning F, Zhou F, Kallon H, et al
    MicroRNAs serve as a bridge between oxidative stress and gastric cancer (Review).
    Int J Oncol. 2016 Sep 9. doi: 10.3892/ijo.2016.3686.
    PubMed     Text format     Abstract available
    
    
    
38. MAEJIMA R, Tamai K, Shiroki T, Yokoyama M, et al
    Enhanced expression of semaphorin 3E is involved in the gastric cancer development.
    Int J Oncol. 2016;49:887-94.
    PubMed     Text format     Abstract available
    
    
    August 2016
39. WEI Y, Zhao L, He W, Yang J, et al
    Benzo[a]pyrene promotes gastric cancer cell proliferation and metastasis likely through the Aryl hydrocarbon receptor and ERK-dependent induction of MMP9 and c-myc.
    Int J Oncol. 2016 Aug 29. doi: 10.3892/ijo.2016.3674.
    PubMed     Text format     Abstract available
    
    
    
40. TANG C, Jiang Y, Shao W, Shi W, et al
    Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer.
    Int J Oncol. 2016 Aug 18. doi: 10.3892/ijo.2016.3661.
    PubMed     Text format     Abstract available
    
    
    
41. XIE P, Fujii I, Zhao J, Shinohara M, et al
    A novel polysaccharide derived from algae extract induces apoptosis and cell cycle arrest in human gastric carcinoma MKN45 cells via ROS/JNK signaling pathway.
    Int J Oncol. 2016 Aug 18. doi: 10.3892/ijo.2016.3658.
    PubMed     Text format     Abstract available
    
    
    
42. ZENG Y, Fu M, Wu GW, Zhang AZ, et al
    Upregulation of microRNA-370 promotes cell apoptosis and inhibits proliferation by targeting PTEN in human gastric cancer.
    Int J Oncol. 2016 Aug 2. doi: 10.3892/ijo.2016.3642.
    PubMed     Text format     Abstract available
    
    
    June 2016
43. KANDA M, Shimizu D, Fujii T, Tanaka H, et al
    Protein arginine methyltransferase 5 is associated with malignant phenotype and peritoneal metastasis in gastric cancer.
    Int J Oncol. 2016 Jun 17. doi: 10.3892/ijo.2016.3584.
    PubMed     Text format     Abstract available
    
    
    
44. ZHANG Y, Li CF, Ma LJ, Ding M, et al
    MicroRNA-224 aggrevates tumor growth and progression by targeting mTOR in gastric cancer.
    Int J Oncol. 2016 Jun 16. doi: 10.3892/ijo.2016.3581.
    PubMed     Text format     Abstract available
    
    
    
45. GUO J, Bian Y, Wang Y, Chen L, et al
    S100A4 influences cancer stem cell-like properties of MGC803 gastric cancer cells by regulating GDF15 expression.
    Int J Oncol. 2016 Jun 2. doi: 10.3892/ijo.2016.3556.
    PubMed     Text format     Abstract available
    
    
    
46. WU D, Mou YP, Chen K, Cai JQ, et al
    Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
    Int J Oncol. 2016 Jun 1. doi: 10.3892/ijo.2016.3551.
    PubMed     Text format     Abstract available
    
    
    May 2016
47. HU J, Shan Z, Hu K, Ren F, et al
    miRNA-223 inhibits epithelial-mesenchymal transition in gastric carcinoma cells via Sp1.
    Int J Oncol. 2016 May 19. doi: 10.3892/ijo.2016.3533.
    PubMed     Text format     Abstract available
    
    
    April 2016
48. SMID D, Kulda V, Srbecka K, Kubackova D, et al
    Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapy.
    Int J Oncol. 2016 Apr 12. doi: 10.3892/ijo.2016.3484.
    PubMed     Text format     Abstract available
    
    
    
49. WU C, Zhuang Y, Jiang S, Liu S, et al
    Interaction between Wnt/beta-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancer (Review).
    Int J Oncol. 2016 Apr 8. doi: 10.3892/ijo.2016.3480.
    PubMed     Text format     Abstract available
    
    
    
50. GAO S, Tan H, Zhu N, Gao H, et al
    Oridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cells.
    Int J Oncol. 2016 Apr 7. doi: 10.3892/ijo.2016.3479.
    PubMed     Text format     Abstract available
    
    
    
51. KIM M, Kim JH, Baek SJ, Kim SY, et al
    Specific expression and methylation of SLIT1, SLIT2, SLIT3, and miR-218 in gastric cancer subtypes.
    Int J Oncol. 2016 Apr 6. doi: 10.3892/ijo.2016.3473.
    PubMed     Text format     Abstract available
    
    
    March 2016
52. ZHU G, Ye J, Huang Y, Zheng W, et al
    Receptor-interacting protein-1 promotes the growth and invasion in gastric cancer.
    Int J Oncol. 2016 Mar 24. doi: 10.3892/ijo.2016.3455.
    PubMed     Text format     Abstract available
    
    
    
53. ZHANG W, Li Y
    miR-148a downregulates the expression of transforming growth factor-beta2 and SMAD2 in gastric cancer.
    Int J Oncol. 2016 Mar 10. doi: 10.3892/ijo.2016.3437.
    PubMed     Text format     Abstract available
    
    
    
54. WANG J, Hu W, Wu X, Wang K, et al
    CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and EKR1/2 phosphorylation.
    Int J Oncol. 2016 Mar 9. doi: 10.3892/ijo.2016.3428.
    PubMed     Text format     Abstract available
    
    
    February 2016
55. LI CY, Liang GY, Yao WZ, Sui J, et al
    Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer.
    Int J Oncol. 2016 Feb 24. doi: 10.3892/ijo.2016.3407.
    PubMed     Text format     Abstract available
    
    
    
56. WANG J, Hu W, Wang K, Yu J, et al
    Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil.
    Int J Oncol. 2016 Feb 2. doi: 10.3892/ijo.2016.3371.
    PubMed     Text format     Abstract available
    
    
    January 2016
57. SHIDA M, Kitajima Y, Nakamura J, Yanagihara K, et al
    Impaired mitophagy activates mtROS/HIF-1alpha interplay and increases cancer aggressiveness in gastric cancer cells under hypoxia.
    Int J Oncol. 2016 Jan 26. doi: 10.3892/ijo.2016.3359.
    PubMed     Text format     Abstract available
    
    
    October 2015
58. WU J, Zhang H, Xu C, Xu H, et al
    TIPE2 functions as a metastasis suppressor via negatively regulating beta-catenin through activating GSK3beta in gastric cancer.
    Int J Oncol. 2015 Oct 30. doi: 10.3892/ijo.2015.3224.
    PubMed     Text format     Abstract available
    
    
    
59. SHEN W, Chen D, Liu S, Chen L, et al
    S100A4 interacts with mutant p53 and affects gastric cancer MKN1 cell autophagy and differentiation.
    Int J Oncol. 2015 Oct 15. doi: 10.3892/ijo.2015.3209.
    PubMed     Text format     Abstract available
    
    
    September 2015
60. DAI J, Wang J, Yang L, Xiao Y, et al
    miR-125a regulates angiogenesis of gastric cancer by targeting vascular endothelial growth factor A.
    Int J Oncol. 2015 Sep 17. doi: 10.3892/ijo.2015.3171.
    PubMed     Text format     Abstract available
    
    
    
61. RAN X, Xu X, Yang Y, She S, et al
    A quantitative proteomics study on olfactomedin 4 in the development of gastric cancer.
    Int J Oncol. 2015 Sep 16. doi: 10.3892/ijo.2015.3168.
    PubMed     Text format     Abstract available
    
    
    
62. KHANNA P, Chua PJ, Bay BH, Baeg GH, et al
    The JAK/STAT signaling cascade in gastric carcinoma (Review).
    Int J Oncol. 2015 Sep 14. doi: 10.3892/ijo.2015.3160.
    PubMed     Text format     Abstract available
    
    
    
63. HE J, Zhu G, Gao L, Chen P, et al
    Fra-1 is upregulated in gastric cancer tissues and affects the PI3K/Akt and p53 signaling pathway in gastric cancer.
    Int J Oncol. 2015 Sep 2. doi: 10.3892/ijo.2015.3146.
    PubMed     Text format     Abstract available
    
    
    August 2015
64. CHEN L, Yuan W, Chen Z, Wu S, et al
    Vasoactive intestinal peptide represses activation of tumor-associated macrophages in gastric cancer via regulation of TNFalpha, IL-6, IL-12 and iNOS.
    Int J Oncol. 2015 Aug 19. doi: 10.3892/ijo.2015.3126.
    PubMed     Text format     Abstract available
    
    
    June 2015
65. MIZUKAMI T, Togashi Y, Sogabe S, Banno E, et al
    EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition.
    Int J Oncol. 2015 Jun 16. doi: 10.3892/ijo.2015.3050.
    PubMed     Text format     Abstract available
    
    
    
66. XIAO K, Yu Z, Shi DT, Lei Z, et al
    Inactivation of BLU is associated with methylation of Sp1-binding site of BLU promoter in gastric cancer.
    Int J Oncol. 2015 Jun 4. doi: 10.3892/ijo.2015.3032.
    PubMed     Text format     Abstract available
    
    
    
67. CHOI PR, Kang YJ, Sung B, Kim JH, et al
    MHY218-induced apoptotic cell death is enhanced by the inhibition of autophagy in AGS human gastric cancer cells.
    Int J Oncol. 2015 Jun 4. doi: 10.3892/ijo.2015.3031.
    PubMed     Text format     Abstract available
    
    
    January 2015
68. TIAN F, Ding D, Li D
    Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.
    Int J Oncol. 2015;46:2355-63.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: